Samsung Biologics
More News
-
Korean prosecutors question Samsung heir in succession-related probe
Prosecutors have been investigating suspected accounting fraud at drug company Samsung Biologics
-
Samsung's bio-drug unit to raise $2 bn in upcoming IPO
The firm makes biopharmaceutical drugs for major firms including Bristol-Myers Squibb and Roche
